"An advanced Cancer Center where over 1,200 highly sub-specialized professionals work together in a multidisciplinary approach to bring customized solutions in a friendly and engaging environment to every patient."

During the past decade, Hackensack University Medical Center Multiple Myeloma Division conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hackensack University Medical Center Multiple Myeloma Division" are "Multiple Myeloma" (1 trials) and "Smoldering Multiple Myeloma" (1 trials). Many other conditions were trialed in "Hackensack University Medical Center Multiple Myeloma Division" in a lesser frequency.

Most popular intervention types in "Hackensack University Medical Center Multiple Myeloma Division" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BHQ880" (1 trials) and "LBH589" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hackensack University Medical Center Multiple Myeloma Division" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hackensack University Medical Center Multiple Myeloma Division". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hackensack University Medical Center Multiple Myeloma Division, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hackensack University Medical Center Multiple Myeloma Division, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".